Effects of acute ultra‐low dose mecamylamine on cognition in adult attention‐deficit/hyperactivity disorder (ADHD)
- 27 May 2009
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 24 (4) , 309-317
Abstract
Objective: Nicotinic cholinergic stimulation has known beneficial effects in attention‐deficit/hyperactivity disorder (ADHD). Mecamylamine is a non‐competitive nicotinic antagonist which is reported in several animal studies to have paradoxical positive effects on cognition at ultra‐low doses. Comparable studies in humans have not been conducted. The aim of this study was to determine the effects of acute ultra‐low doses of mecamylamine on cognition in adult ADHD.Methods: Fifteen (6 female) non‐smokers with ADHD completed this acute, within subjects, double blind study of 0.2, 0.5, 1.0 mg of oral mecamylamine and placebo. Behavioral inhibition, recognition memory, and delay aversion were assessed at each dose.Results: The 0.5 mg dose of mecamylamine significantly improved recognition memory and reduced tolerance for delay. Mecamylamine increased participant rated irritability and investigator rated restlessness. There were no effects on vital signs or physical side effects.Conclusion: This is the first study to find measurable effects of ultra‐low doses of mecamylamine in humans. Mecamylamine did not improve core ADHD cognitive symptoms, but significantly improved recognition memory. These effects may represent mixed receptor activity (activation and blockade) at the doses tested. The finding of beneficial effects on memory processes has important clinical implications and further exploration of this effect is warranted. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 43 references indexed in Scilit:
- Nicotinic Versus Muscarinic Blockade Alters Verbal Working Memory-Related Brain Activity in Older WomenThe American Journal of Geriatric Psychiatry, 2008
- Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorderPharmacology Biochemistry and Behavior, 2008
- Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: Evidence for the critical period hypothesisHormones and Behavior, 2008
- Central nicotinic cholinergic systems: A role in the cognitive dysfunction in Attention-Deficit/Hyperactivity Disorder?Behavioural Brain Research, 2006
- Neuropsychological functioning in people with ADHD across the lifespanClinical Psychology Review, 2006
- Effects of nicotinic stimulation on cognitive performanceCurrent Opinion in Pharmacology, 2004
- Development of inhibitory control across the life span.Developmental Psychology, 1999
- Cognitive functions of cortical acetylcholine: toward a unifying hypothesisBrain Research Reviews, 1997
- Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD.Psychological Bulletin, 1997
- In Vivo Regulation of [3H]Acetylcholine Recognition Sites in Brain by Nicotinic Cholinergic DrugsJournal of Neurochemistry, 1985